Improving outcome in elderly patients with pneumonia Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005
Epidemiology of antibiotics prescribtion for treatment of hospital-acquired pnemonia (HAP) in ICU Source: Eur Respir J 2004; 24: Suppl. 48, 547s Year: 2004
Relevance of correct antibiotic choice in community-acquired pneumonia (CAP) Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005
A prospective comparison of nursing home acquired pneumonia (NAP) with community acquired pneumonia (CAP) Source: Eur Respir J 2005; 26: Suppl. 49, 257s Year: 2005
Effectiveness of the empirical administration of antibiotics in community acquired pneumonia (CAP) Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007
Initial intravenous antibiotic regimen in patients hospitalized for community acquired pneumonia (CAP) in France Source: Eur Respir J 2003; 22: Suppl. 45, 151s Year: 2003
The efficiency of levofloxacin in the therapy of community acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 5s Year: 2006
Emergency treatment of communityacquired pneumonia Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=183 Year: 2006
Prevalence of penicillin resistant pneumococci among children with community acquired pneumonia admitted in a secondary reference hospital – 5 year study Source: Eur Respir J 2006; 28: Suppl. 50, 494s Year: 2006
Hospital treatment of community acquired pneumonia in children with penicillin Source: Annual Congress 2009 - Bacterial infections of upper and lower respiratory tract in childhood Year: 2009
Corticosteroids and community-acquired pneumonia Source: Annual Congress 2007 - Corticosteroids and respiratory failure Year: 2007
Cost-effective antibiotic management of community acquired pneumonia Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=198 Year: 2004
Monotherapy with β-lactamic antibiotics or macrolides vs their combination for the treatment of community acquired pneumonia (CAP) Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008
Hospital-acquired pneumonia: microbiological data and potential adequacy of antimicrobial regimens Source: Eur Respir J 2002; 20: 432-439 Year: 2002
The usage of laferon in treatment of patients with community acquired pneumonia (CAP) Source: Eur Respir J 2007; 30: Suppl. 51, 675s Year: 2007
Clinical stability in patients with community- acquired pneumonia (CAP) Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011
Healthcare-associated pneumonia among hospitalized patients. Is it really different from community acquired pneumonia? Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012
Health care associated pneumonia (HCAP) and community acquired pneumonia (CAP): Are they different diseases? Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010
Factors related to obtain an etiological diagnosis in community acquired pneumonia (CAP) Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007
Etiological features of late nosocomial pneumonia (NP) in patients of general surgical departments who had a prior antibacterial therapy (PAT) Source: Eur Respir J 2006; 28: Suppl. 50, 786s Year: 2006